BCOR and myelodysplastic syndrome: In contrast, the TET2, FLT3, RUNX1, BCOR and spliceosome mutations were more common in the IDO1-high group, which were commonly enriched in myelodysplastic syndrome (MDS)-transformed AML (Table S3).